🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

493 results for “Regeneron UK Limited” Clear

  1. REGV131

    Regeneron UK Limited

    Hemophilia B

    phase 2 small molecule active

    1 trial

  2. Rilonacept

    Regeneron UK Limited

    Cold Contact Urticaria

    phase 2 small molecule completed

    1 trial

  3. Rilonacept

    Regeneron UK Limited

    Chronic Kidney Disease

    phase 2 small molecule terminated

    1 trial

  4. Rilonacept

    Regeneron UK Limited

    Scleroderma

    phase 2 small molecule completed

    1 trial

  5. S095018

    Regeneron UK Limited

    Non-small Cell Lung Cancer (NSCLC)

    phase 2 small molecule active

    1 trial

  6. SAR440340

    Regeneron UK Limited

    Asthma

    phase 2 small molecule completed

    1 trial

  7. SAR440340

    Regeneron UK Limited

    Chronic Obstructive Pulmonary Disease

    phase 2 small molecule completed

    1 trial

  8. SAR444881

    Regeneron UK Limited

    Solid Tumors

    phase 2 small molecule active

    1 trial

  9. SDREGN2810

    Regeneron UK Limited

    Advanced Non-Small Cell Lung Carcinoma

    phase 2 small molecule terminated

    1 trial

  10. SNS-101 (anti-VISTA)

    Regeneron UK Limited

    Solid Tumor, Adult

    phase 2 small molecule active

    1 trial

  11. Sarilumab

    Regeneron UK Limited

    Juvenile Idiopathic Arthritis

    phase 2 small molecule completed

    1 trial

  12. Sarilumab

    Regeneron UK Limited

    Morphea, Plaque Form

    phase 2 small molecule terminated

    1 trial

  13. Sarilumab

    Regeneron UK Limited

    Ankylosing Spondylitis

    phase 2 small molecule terminated

    2 trials

  14. Sarilumab SAR153191 (REGN88)

    Regeneron UK Limited

    Juvenile Idiopathic Arthritis

    phase 2 small molecule active

    1 trial

  15. Sub-tenon injection of saline followed by a sub-tenon injection of aflibercept

    Regeneron UK Limited

    Thyroid Eye Disease

    phase 2 small molecule completed

    1 trial

  16. Tirzepatide

    Regeneron UK Limited

    Obesity

    phase 2 small molecule completed

    1 trial

  17. Trevogrumab-Part A

    Regeneron UK Limited

    Obesity

    phase 2 small molecule active

    1 trial

  18. Ubamatamab

    Regeneron UK Limited

    Recurrent Ovarian Cancer

    phase 2 small molecule active

    1 trial

  19. Ubamatamab

    Regeneron UK Limited

    Ovarian Cancer

    phase 2 small molecule active

    1 trial

  20. Ubamatamab

    Regeneron UK Limited

    Advanced/Metastatic Non-Small Cell Lung Cancer

    phase 2 small molecule active

    1 trial

  21. Ubamatamab

    Regeneron UK Limited

    SMARCB1-Deficient Malignancies

    phase 2 small molecule active

    1 trial

  22. VEGF Trap Eye

    Regeneron UK Limited

    Macular Degeneration

    phase 2 small molecule completed

    1 trial

  23. VV1

    Regeneron UK Limited

    Melanoma

    phase 2 mab active

    1 trial

  24. Vonsetamig

    Regeneron UK Limited

    Chronic Kidney Disease (CKD)

    phase 2 small molecule active

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources